|
Volumn 318, Issue 7178, 1999, Pages 224-228
|
Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): Results of phase II trials in Italy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BROMOCRIPTINE;
CYCLOPHOSPHAMIDE;
HYDROXYUREA;
MELATONIN;
OCTREOTIDE;
RETINOID;
SOMATOSTATIN;
ADULT;
ADVANCED CANCER;
AGED;
ANEMIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER MORTALITY;
CANCER REGRESSION;
CANCER THERAPY;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFICACY;
FEMALE;
GASTROINTESTINAL DISEASE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ITALY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
NONHODGKIN LYMPHOMA;
ORAL DRUG ADMINISTRATION;
PANCREAS CANCER;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOMNOLENCE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VOMITING;
WORLD HEALTH ORGANIZATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BROMOCRIPTINE;
COMPLEMENTARY THERAPIES;
FEMALE;
HUMANS;
MALE;
MELATONIN;
MIDDLE AGED;
NEOPLASMS;
OCTREOTIDE;
SOMATOSTATIN;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
TRETINOIN;
|
EID: 0033596580
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (48)
|
References (8)
|